Experts are cautiously excited about ‘real-time’ FDA clinical trials
The FDA announced its idea for speedier drug approvals on April 28.
How clinical trials is shaping the future of healthcare, featuring expert insights, data-driven stories, and the latest industry developments.
The FDA announced its idea for speedier drug approvals on April 28.
In the words of Leslie Knope: “Diabetes. Let’s dia-beat-this!”
“Slow and steady” beats “flashy” when it comes to treating cancer, CEO Ben Zeskind says.
Testing the safety and efficacy of medications will still depend on the company and the disease.
Investors were seemingly not satisfied with psilocybin trial results, but the psychedelic health community disagrees.
Oink if you love science!
Digital twins can cut time and costs associated with running drug studies.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.